Balderton Capital, a London-based venture capital fund with a focus on ambitious entrepreneurs, disruptive technology and sustainable businesses, led the series D financing round over USD 30m in Sophia Genetics SA, one of the world’s foremost companies in the field of applying artificial intelligence to genomic analysis.
VISCHER acted as transaction counsel to Balderton Capital. The team was led by Christian Wyss (Partner) and supported by Luzius Zumstein (Associate) and Aron Waltuch (Trainee), all Corporate.